Clinical Chemistry and Laboratory Medicine

Article	Citations
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence	140
Development, evaluation, and validation of machine learning models for COVID-19 detection based on routine blood tests	102
Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation	91
Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody	72
Low levels of total and ionized calcium in blood of COVID-19 patients	72
Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors	63
Evaluation of the automated LIAISON® SARS-CoV-2 TrimericS IgG assay for the detection of circulating antibodies	61
SARS-CoV-2 serosurvey in health care workers of the Veneto Region	58
IFCC Interim Guidelines on Serological Testing of Antibodies against SARS-CoV-2	57
Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers	56
Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019	52
COVID-19: progression of disease and intravascular coagulation – present status and future perspectives	52
Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?	50
Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR	48
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid	47
SARS-CoV-2 RNA identification in nasopharyngeal swabs: issues in pre-analytics	47
Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing	47
Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study	45
Monocyte distribution width (MDW) as a screening tool for sepsis in the Emergency Department	45
IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection	44
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers	43
The emerging role of cell senescence in atherosclerosis	43
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series	42
Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine	42
Volumetric absorptive microsampling and dried blood spot microsampling vs. conventional venous sampling for tacrolimus trough concentration monitoring	41

The European Biological Variation Study (EuBIVAS): a summary report	41
Thrombin generation in patients with COVID-19 with and without thromboprophylaxis	40
Performance specifications for measurement uncertainty of common biochemical measurands according to Milan models	39
ChatGPT, critical thing and ethical practice	39
Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows	39
Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations	39
Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkers	39
Potentials and pitfalls of ChatGPT and natural-language artificial intelligence models for the understanding of laboratory medicine test results. An assessment by the European Federation of Clinical C	38
Monocyte distribution width (MDW) parameter as a sepsis indicator in intensive care units	38
Blood biochemical characteristics of patients with coronavirus disease 2019 (COVID-19): a systemic review and meta-analysis	37
Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient	36
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals	35
Non-invasive determination of uric acid in human saliva in the diagnosis of serious disorders	35
Clinical relevance of biological variation of cardiac troponins	35
The CRESS checklist for reporting stability studies: on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)	35
Erythrocyte sedimentation rate is associated with severe coronavirus disease 2019 (COVID-19): a pooled analysis	34
Interferences in immunoassays: review and practical algorithm	34
IFCC Interim Guidelines on Biochemical/Hematological Monitoring of COVID-19 Patients	33
Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19	32
Why C-reactive protein is one of the most requested tests in clinical laboratories?	32
Evaluation of three fully-automated SARS-CoV-2 antibody assays	32
The new, race-free, Chronic Kidney Disease Epidemiology Consortium (CKD-EPI) equation to estimate glomerular filtration rate: is it applicable in Europe? A position statement by the European Federatio	31
Blood lactate concentration in COVID-19: a systematic literature review	31
Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma	31
Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassays	30
Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays	30
Vitamin-D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients	30
The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus	29
Automation and validation of a MALDI-TOF MS (Mass-Fix) replacement of immunofixation electrophoresis in the clinical lab	29
Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients	29
Review and evolution of guidelines for diagnosis of COVID-19 vaccine induced thrombotic thrombocytopenia (VITT)	28
Artificial intelligence in clinical applications for lung cancer: diagnosis, treatment and prognosis	28
The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors	27
Simultaneous measurement of 13 circulating vitamin D3 and D2 mono and dihydroxy metabolites using liquid chromatography mass spectrometry	27
The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study	27
Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing	25
Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer	25
Determination of sex-specific 99th percentile upper reference limits for a point of care high sensitivity cardiac troponin I assay	25
Low free-T3 serum levels and prognosis of COVID-19: systematic review and meta-analysis	25
Evaluation of the first immunosuppressive drug assay available on a fully automated LC-MS/MS-based clinical analyzer suggests a new era in laboratory medicine	25
Circulating tumor DNA (ctDNA) as a pan-cancer screening test: is it finally on the horizon?	25
Homocysteine (Hcy) assessment to predict outcomes of hospitalized Covid-19 patients: a multicenter study on 313 Covid-19 patients	24
The end of the laboratory developed test as we know it? Recommendations from a national multidisciplinary taskforce of laboratory specialists on the interpretation of the IVDR and its complications	23
Consideration should be given to smoking, endometriosis, renal function (eGFR) and age when interpreting CA125 and HE4 in ovarian tumor diagnostics	23
Monocyte distribution width (MDW) as a screening tool for early detecting sepsis: a systematic review and meta-analysis	23
Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay	23
Self-sampling at home using volumetric absorptive microsampling: coupling analytical evaluation to volunteers’ perception in the context of a large scale study	23
Commercial immunoassays for detection of anti-SARS-CoV-2 spike and RBD antibodies: urgent call for validation against new and highly mutated variants	23
European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates for serum thyroid biomarkers based on weekly samplings from 91 healthy participants	23
High-sensitivity cardiac troponins in pediatric population	22

Saliva – a new opportunity for fluid biopsy	22
Benefits, limitations and controversies on patient-based real-time quality control (PBRTQC) and the evidence behind the practice	22
A biological profile for diagnosis and outcome of COVID-19 patients	22
Kinetics and biological characteristics of humoral response developing after SARS-CoV-2 infection: implications for vaccination	21
Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey	21
Harmonization of antineutrophil cytoplasmic antibodies (ANCA) testing by reporting test result-specific likelihood ratios: position paper	21
Editorial and Executive Summary: IFCC Interim Guidelines on Clinical Laboratory testing during the COVID-19 Pandemic	21
Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS	21
The underestimated issue of non-reproducible cardiac troponin I and T results: case series and systematic review of the literature	21
Antibody tests for COVID-19: drawing attention to the importance of analytical specificity	21
Validation of the Corona-Score for rapid identification of SARS-CoV-2 infections in patients seeking emergency department care in the United States	20
Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey	20
Reference intervals for Sysmex XN hematological parameters as assessed in the Dutch Lifelines cohort	20
The new IVD Regulation 2017/746: a case study at a large university hospital laboratory in Belgium demonstrates the need for clarification on the degrees of freedom laboratories have to use lab-develo	20
Pre-analytical stability of serum biomarkers for neurological disease: neurofilament-light, glial fibrillary acidic protein and contactin-1	20
An approach for determining allowable between reagent lot variation	20
Evaluation of dried blood spots as alternative sampling material for serological detection of anti-SARS-CoV-2 antibodies using established ELISAs	20
Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2	20
A new tool for sepsis screening in the Emergency Department	19
How is test laboratory data used and characterised by machine learning models? A systematic review of diagnostic and prognostic models developed for COVID-19 patients using only laboratory data	19
Cytokine “storm”, cytokine “breeze”, or both in COVID-19?	19
Protease-antiprotease imbalance in patients with severe COVID-19	19
Biological variation of serum neurofilament light chain	19
Lumipulse G SARS-CoV-2 Ag assay evaluation using clinical samples from different testing groups	19
Implementation of the new EU IVD regulation – urgent initiatives are needed to avert impending crisis	19
Within- and between-subject biological variation data for tumor markers based on the European Biological Variation Study	19
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital	19
Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study	18
Comparability of 11 different equations for estimating LDL cholesterol on different analysers	18
Optimizing effectiveness of COVID-19 vaccination: will laboratory stewardship play a role?	18
Mechanism of bilirubin elimination in urine: insights and prospects for neonatal jaundice	18
Hemoglobin variants in southern China: results obtained during the measurement of glycated hemoglobin in a large population	18
Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study	18
Lot-to-lot reagent verification: challenges and possible solutions	18
Artificial intelligence in laboratory medicine: fundamental ethical issues and normative key-points	17
Hypoalbuminemia and elevated D-dimer in COVID-19 patients: a call for result harmonization	17
No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection	17
Prognostic role of Krebs von den Lungen-6 (KL-6) measurement in idiopathic pulmonary fibrosis: a systematic review and meta-analysis	17
ISO 15189 is a sufficient instrument to guarantee high-quality manufacture of laboratory developed tests for in-house-use conform requirements of the European In-Vitro-Diagnostics Regulation	17
Derivation of performance specifications for uncertainty of serum C-reactive protein measurement according to the Milan model 3 (state of the art)	17
FGF23 measurement in burosumab-treated patients: an emerging treatment may induce a new analytical interference	16
Exploring the possibilities of infrared spectroscopy for urine sediment examination and detection of pathogenic bacteria in urinary tract infections	16
Comparison of different algorithms in laboratory diagnosis of alpha1-antitrypsin deficiency	16
D-dimer: old dogmas, new (COVID-19) tricks	16
Harmonising EQA schemes the next frontier: challenging the status quo	16
Quality performance for indirect Xa inhibitor monitoring in patients using international external quality data	15
Definition and application of performance specifications for measurement uncertainty of 23 common laboratory tests: linking theory to daily practice	15
Optimizing hepcidin measurement with a proficiency test framework and standardization improvement	15
Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals	15
Diagnostic performance of the fully automated Roche Elecsys SARS-CoV-2 antigen electrochemiluminescence immunoassay: a pooled analysis	15
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?	15
High-resolution pediatric reference intervals for 15 biochemical analytes described using fractional polynomials	15
Lactate dehydrogenase: an old enzyme reborn as a COVID-19 marker (and not only)	15
An original multiplex method to assess five different SARS-CoV-2 antibodies	15
Ageing, ACE2 deficiency and bad outcome in COVID-19	15
Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference	15
Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort	15
Biological variation estimates of thyroid related measurands – meta-analysis of BIVAC compliant studies	15
The versatility of external quality assessment for the surveillance of laboratory and in vitro diagnostic performance: SARS-CoV-2 viral genome detection in Austria	14
Analytical assessment of ortho clinical diagnostics high-sensitivity cardiac troponin I assay	14
A cohort analysis of SARS-CoV-2 anti-spike protein receptor binding domain (RBD) IgG levels and neutralizing antibodies in fully vaccinated healthcare workers	14
Harmonization status of procalcitonin measurements: what do comparison studies and EQA schemes tell us?	14
Flowing through laboratory clinical data: the role of artificial intelligence and big data	14
The combined use of enzyme activity and metabolite assays as a strategy for newborn screening of mucopolysaccharidosis type I	14
Serum GFAP – reference interval and preanalytical properties in Danish adults	14
Redesigning the surveillance of in vitro diagnostic medical devices and of medical laboratory performance by quality control in the traceability era	14
Health Technology Assessment to assess value of biomarkers in the decision-making process	14
Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice	14
Where is laboratory medicine headed in the next decade? Partnership model for efficient integration and adoption of artificial intelligence into medical laboratories	14
Using machine learning to identify clotted specimens in coagulation testing	14
Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients	14
Laboratory medicine in the COVID-19 era: six lessons for the future	14
Intra- and inter-cycle variability of anti-Müllerian hormone (AMH) levels in healthy women during non-consecutive menstrual cycles: the BICYCLE study	13
Preliminary evaluation of Roche Cobas Elecsys Anti-SARS-CoV-2 chemiluminescence immunoassay	13
Critical appraisal and meta-analysis of biological variation estimates for kidney related analytes	13
Ad interim recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working group	13
Stabilization patterns and variability of hs-CRP, NT-proBNP and ST2 during 1 year after acute coronary syndrome admission: results of the BIOMArCS study	13
Is thyroglobulin a reliable biomarker of differentiated thyroid cancer in patients treated by lobectomy? A systematic review and meta-analysis	13
Distribution of HOMA-IR in a population-based cohort and proposal for reference intervals	13
Critical review and meta-analysis of biological variation estimates for tumor markers	13

Anti-phosphatidyl-serine/prothrombin antibodies (aPS/PT) in isolated lupus anticoagulant (LA): is their presence linked to dual test positivity?	13
How to meet ISO15189:2012 pre-analytical requirements in clinical laboratories? A consensus document by the EFLM WG-PRE	13
Continuous monitoring of SARS-CoV-2 seroprevalence in children using residual blood samples from routine clinical chemistry	13
Complex analytical procedures in diagnostic laboratories and the IVDR	12
Reference values of trace elements in blood and/or plasma in adults living in Belgium	12
Variability of cardiac troponin levels in normal subjects and in patients with cardiovascular diseases: analytical considerations and clinical relevance	12
Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis	12
Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer	12
Common laboratory tests as indicators of COVID-19 severity on admission at high altitude: a single-center retrospective study in Quito (ECUADOR)	12
An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure (RMP) for the quantification of aldosterone in human serum and plasma	12
Rethinking internal quality control: the time is now	12
Independent and combined effects of biotin and hemolysis on high-sensitivity cardiac troponin assays	12
Evaluation of an ELISA for SARS-CoV-2 antibody testing: clinical performances and correlation with plaque reduction neutralization titer	12
Report from the HarmoSter study: impact of calibration on comparability of LC-MS/MS measurement of circulating cortisol, 17OH-progesterone and aldosterone	12
The importance of correct stratifications when comparing directly and indirectly estimated reference intervals	12
Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: a patient-level meta-analysis from randomized controlled trials	12
Personalized reference intervals – statistical approaches and considerations	12
Analytical evaluation of four faecal immunochemistry tests for haemoglobin	12
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections	12
Complete blood counts and cell population data from Sysmex XN analyser in the detection of SARS-CoV-2 infection	12
A novel scoring system combining Modified Early Warning Score with biomarkers of monocyte distribution width, white blood cell counts, and neutrophil-to-lymphocyte ratio to improve early sepsis predic	12
Clinical risk assessment of biotin interference with a high-sensitivity cardiac troponin T assay	12
Simple and accurate quantitative analysis of cefiderocol and ceftobiprole in human plasma using liquid chromatography-isotope dilution tandem mass spectrometry: interest for their therapeutic drug mon	11
Global FT4 immunoassay standardization: an expert opinion review	11
Reference values for plasma neurofilament light chain in healthy Chinese children	11
Using artificial intelligence in a primary care setting to identify patients at risk for cancer: a risk prediction model based on routine laboratory tests	11
Automated prediction of low ferritin concentrations using a machine learning algorithm	11
Clinical performance of calcitonin and procalcitonin Elecsys® immunoassays in patients with medullary thyroid carcinoma	11
Derivation of sex and age-specific reference intervals for clinical chemistry analytes in healthy Ghanaian adults	11
Procalcitonin measured by three different assays is an excellent tumor marker for the follow-up of patients with medullary thyroid carcinoma	11
Statistics in diagnostic medicine	11
Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign	11
Non-HDL-C/TG ratio indicates significant underestimation of calculated low-density lipoprotein cholesterol (LDL-C) better than TG level: a study on the reliability of mathematical formulas used for LD	11
Biological variation: recent development and future challenges	11
ACE Ins/Del genetic polymorphism and epidemiological findings in COVID-19	11
High-sensitivity assay for cardiac troponins with POCT methods. The future is soon	11
Analytical validation of an automated assay for the measurement of adenosine deaminase (ADA) and its isoenzymes in saliva and a pilot evaluation of their changes in patients with SARS-CoV-2 infection	11
Performance evaluation of an automated SARS-CoV-2 Ag test for the diagnosis of COVID-19 infection on nasopharyngeal swabs	11
Individual risk prediction of high grade prostate cancer based on the combination between total prostate-specific antigen (PSA) and free to total PSA ratio	11
The early antibody response to SARS-Cov-2 infection	11
Reference values for plasma neurofilament light chain (NfL) in healthy Chinese	11
A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil population data on Sysmex XN-series analysers	11
A word of caution on using tumor biomarker reference change values to guide medical decisions and the need for alternatives	11
Emicizumab, the factor VIII mimetic bi-specific monoclonal antibody and its measurement in plasma	11
Comparison of the analytical performance of the PATHFAST high sensitivity cardiac troponin I using fresh whole blood vs. fresh plasma samples	11
Comparison of the diagnostic performance with whole blood and plasma of four rapid antibody tests for SARS-CoV-2	11
Performance of digital morphology analyzer Vision Pro on white blood cell differentials	10
Re-examining ferritin-bound iron: current and developing clinical tools	10
Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients	10
Trimethylamine-N-oxide (TMAO) predicts short- and long-term mortality and poor neurological outcome in out-of-hospital cardiac arrest patients	10
Sample size and rejection limits for detecting reagent lot variability: analysis of the applicability of the Clinical and Laboratory Standards Institute (CLSI) EP26-A protocol to real-world clinical c	10
Digital transformation and sustainability in healthcare and clinical laboratories	10
Critical role of pre-analytical aspects for the measurement of circulating calprotectin in serum or plasma as a biomarker for neutrophil-related inflammation	10
Current performance of C-reactive protein determination and derivation of quality specifications for its measurement uncertainty	10
Monocyte distribution width (MDW): a useful biomarker to improve sepsis management in Emergency Department	10
Comparison of the reliability of Gram-negative and Gram-positive flags of the Sysmex UF-5000 with manual Gram stain and urine culture results	10
Lot-to-lot variation: no longer a neglected issue	10
Managing COVID-19 outbreak in Nigeria: matters arising	10
Pooling for SARS-CoV-2-testing: comparison of three commercially available RT-qPCR kits in an experimental approach	10
The multicenter European Biological Variation Study (EuBIVAS): a new glance provided by the Principal Component Analysis (PCA), a machine learning unsupervised algorithms, based on the basic metabolic	10
Metrological traceability and clinical traceability of laboratory results – the role of commutability in External Quality Assurance	10
Comparison of two LC-MS/MS methods for the quantification of 24,25-dihydroxyvitamin D3 in patients and external quality assurance samples	10
Ultrasensitive assay for saliva-based SARS-CoV-2 antigen detection	10
Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection	10
Does COVID-19 alter the oxyhemoglobin dissociation curve? – An observational cohort study using a mixed-effect modelling	10
Pre-analytical considerations in biomarker research: focus on cardiovascular disease	10
Quality indicators in laboratory medicine: state-of-the-art, quality specifications and future strategies	10
Identification of macrotroponin T: findings from a case report and non-reproducible troponin T results	10
Detection of antinuclear antibodies: recommendations from EFLM, EASI and ICAP	10
Urinalysis parameters for predicting severity in coronavirus disease 2019 (COVID-19)	10
From big data to better patient outcomes	9
Diagnostic performance of a SARS-CoV-2 IgG/IgM lateral flow immunochromatography assay in symptomatic patients presenting to the emergency department	9
Improving measurement uncertainty of plasma electrolytes: a complex but not impossible task	9
Stability of direct renin concentration and plasma renin activity in EDTA whole blood and plasma at ambient and refrigerated temperatures from 0 to 72 hours	9
Biological variation – eight years after the 1st Strategic Conference of EFLM	9
Individual uromodulin serum concentration is independent of glomerular filtration rate in healthy kidney donors	9
Overcoming challenges regarding reference materials and regulations that influence global standardization of medical laboratory testing results	9
Reference intervals for venous blood gas measurement in adults	9
Evaluation of seven commercial SARS-CoV-2 RNA detection kits based on real-time polymerase chain reaction (PCR) in China	9
Imperative: reducing the environmental impact of clinical laboratories	9
Detection and functional characterization of a novel MEF2A variation responsible for familial dilated cardiomyopathy	9
Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood	9
Towards 50 years of platelet function analyser (PFA) testing	9
Non-reproducible cardiac troponin results occurring with a particular reagent lot	9
Within- and between-subject biological variation data for serum zinc, copper and selenium obtained from 68 apparently healthy Turkish subjects	9
Isotope dilution LC-MS/MS quantification of the cystic fibrosis transmembrane conductance regulator (CFTR) modulators ivacaftor, lumacaftor, tezacaftor, elexacaftor, and their major metabolites in hum	9
Use of high-sensitivity cardiac troponins in the emergency department for the early rule-in and rule-out of acute myocardial infarction without persistent ST-segment elevation (NSTEMI) in Italy	9
Performance of three automated SARS-CoV-2 antibody assays and relevance of orthogonal testing algorithms	9
Integrating quality assurance in autoimmunity: the changing face of the automated ANA IIF test	9
Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay	9
Biological variation of cardiac myosin-binding protein C in healthy individuals	9
The high frequency of anti-PF4/heparin antibodies in patients with COVID-19 is neither related to heparin treatment or to an increased incidence of thrombosis	9
Interpretable machine learning model to detect chemically adulterated urine samples analyzed by high resolution mass spectrometry	9
Deciphering the role of monocyte and monocyte distribution width (MDW) in COVID-19: an updated systematic review and meta-analysis	9
A multi-laboratory assessment of congenital thrombophilia assays performed on the ACL TOP 50 family for harmonisation of thrombophilia testing in a large laboratory network	9